Skip to main content
. 2017 Sep 6;19(10):830–841. doi: 10.1016/j.neo.2017.08.002

Supplementary Figure 12.

Supplementary Figure 12

Percentage of HCT116 wt, p53−/−, and 21−/− cells with phosphorylation (Ser10) of histone 3 (p-H3) (flow cytometry) following their pretreatment (2 hours) with SCH900776 (SCH, 3 μM) and subsequent treatment (48 hours) with LA-12 (0.75 μM) or cisplatin (CDDP, 20 μM). Results are means ± SEM of three independent experiments. Statistical significance: P < .05, * versus control, ‡ versus SCH, Ο versus LA-12 or CDDP and Δ for wt versus p53−/− or wt versus p21−/−